$NCRA
NOCERA, INC.

2023 Q2 Form 10-Q Financial Statement

#000168316823003342 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $5.327M $5.352K $9.861M
YoY Change 143.85% -99.82% 39.28%
Cost Of Revenue $5.290M $3.769M $9.711M
YoY Change 148.23% 31.62% 49.28%
Gross Profit $37.24K $68.66K $149.5K
YoY Change -30.47% 24.26% -73.98%
Gross Profit Margin 0.7% 1282.81% 1.52%
Selling, General & Admin $368.7K $1.059M $3.269M
YoY Change -15.71% 23.04% -65.98%
% of Gross Profit 990.12% 1542.97% 2186.46%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $36.88K $44.73K $70.82K
YoY Change 8023.35% 5561.77% 5432.81%
% of Gross Profit 99.05% 65.15% 47.37%
Operating Expenses $368.7K $1.059M $3.269M
YoY Change -15.71% 23.04% -65.98%
Operating Profit -$331.4K -$990.7K -$3.119M
YoY Change -13.65% 22.96% -65.48%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$880.00 -$11.51K $409.9K
YoY Change -144.02% -157757.69%
Pretax Income -$332.3K -$1.002M -$2.710M
YoY Change -12.97% 24.39% -70.01%
Income Tax $0.00 $0.00 -$23.39K
% Of Pretax Income
Net Earnings -$311.4K -$987.6K -$2.758M
YoY Change -18.91% 22.58% -69.77%
Net Earnings / Revenue -5.85% -18453.81% -27.97%
Basic Earnings Per Share -$0.03 -$0.11
Diluted Earnings Per Share -$0.03 -$0.11 -$0.30
COMMON SHARES
Basic Shares Outstanding 9.694M shares 9.244M shares
Diluted Shares Outstanding 9.694M shares 9.294M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.116M $1.461M $2.906M
YoY Change -30.24% -25.55% 18.91%
Cash & Equivalents $1.116M $1.461M $2.906M
Short-Term Investments
Other Short-Term Assets $204.9K $202.7K $1.730K
YoY Change 1083.2% 1031.03% -95.97%
Inventory $86.28K $91.33K $91.78K
Prepaid Expenses
Receivables $201.1K $206.8K $209.8K
Other Receivables $7.920K $7.420K $27.47K
Total Short-Term Assets $1.616M $1.969M $3.237M
YoY Change -66.52% -68.38% -49.41%
LONG-TERM ASSETS
Property, Plant & Equipment $1.626M $1.686M $844.6K
YoY Change 2377.15% 2364.12% 1085.5%
Goodwill $3.906M $3.906M $3.906M
YoY Change 1076.28% 1076.28%
Intangibles $122.3K $126.4K $130.4K
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.664K $4.770K $0.00
YoY Change
Total Long-Term Assets $5.681M $5.746M $4.903M
YoY Change 1243.28% 1181.41% 937.17%
TOTAL ASSETS
Total Short-Term Assets $1.616M $1.969M $3.237M
Total Long-Term Assets $5.681M $5.746M $4.903M
Total Assets $7.297M $7.715M $8.140M
YoY Change 38.99% 15.59% 18.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $2.482K $2.631K
YoY Change -100.0% -84.92%
Accrued Expenses $820.00 $870.00 $860.00
YoY Change -96.17% -97.77% -99.34%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Long-Term Debt Due $169.4K $217.1K $214.9K
YoY Change
Total Short-Term Liabilities $1.423M $1.487M $1.522M
YoY Change 45.29% -24.7% -27.56%
LONG-TERM LIABILITIES
Long-Term Debt $394.4K $400.5K $436.3K
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $394.4K $400.5K $436.3K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.423M $1.487M $1.522M
Total Long-Term Liabilities $394.4K $400.5K $436.3K
Total Liabilities $1.818M $1.887M $1.958M
YoY Change 85.55% -4.42% -6.79%
SHAREHOLDERS EQUITY
Retained Earnings -$16.05M -$15.74M -$14.75M
YoY Change 44.46% 48.69%
Common Stock $9.693K $9.693K $9.243K
YoY Change -9.47% -12.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.377M $5.701M $6.041M
YoY Change
Total Liabilities & Shareholders Equity $7.297M $7.715M $8.140M
YoY Change 38.99% 15.59% 18.48%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$311.4K -$987.6K -$2.758M
YoY Change -18.91% 22.58% -69.77%
Depreciation, Depletion And Amortization $36.88K $44.73K $70.82K
YoY Change 8023.35% 5561.77% 5432.81%
Cash From Operating Activities -$285.5K -$364.4K -$1.242M
YoY Change 222.33% -34.14% -531.02%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $857.9K -$836.4K
YoY Change 8363900.0%
Acquisitions
YoY Change
Other Investing Activities $950.00 -$201.0K $261.4K
YoY Change
Cash From Investing Activities $950.00 -$1.059M $1.098M
YoY Change -10977600.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -39.89K -$41.14K 677.0K
YoY Change 70.47% 1092.38% -55.02%
NET CHANGE
Cash From Operating Activities -285.5K -$364.4K -1.242M
Cash From Investing Activities 950.0 -$1.059M 1.098M
Cash From Financing Activities -39.89K -$41.14K 677.0K
Net Change In Cash -324.5K -$1.446M 532.9K
YoY Change 189.75% 159.66% -70.29%
FREE CASH FLOW
Cash From Operating Activities -$285.5K -$364.4K -$1.242M
Capital Expenditures $0.00 $857.9K -$836.4K
Free Cash Flow -$285.5K -$1.222M -$405.5K
YoY Change 222.33% 120.91% -240.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001756180
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
pure
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2023Q1 dei Entity File Number
EntityFileNumber
000-55993
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
NOCERA, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
16-1626611
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3F (Building B)
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
No. 185
CY2023Q1 dei Entity Address Address Line3
EntityAddressAddressLine3
Sec. 1
CY2023Q1 NCRA Entity Address Address Line4
EntityAddressAddressLine4
Datong Rd
CY2023Q1 NCRA Entity Address Address Line5
EntityAddressAddressLine5
Xizhi Dist
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New Taipei City
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
221
CY2023Q1 dei Entity Address Country
EntityAddressCountry
TW
CY2023Q1 dei City Area Code
CityAreaCode
886
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
910-163-358
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
NCRA
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9693587 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1460504 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2906074 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
206784 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
209777 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
91329 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
91781 usd
CY2023Q1 NCRA Advance To Suppliers
AdvanceToSuppliers
1732 usd
CY2022Q4 NCRA Advance To Suppliers
AdvanceToSuppliers
1732 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7419 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27470 usd
CY2023Q1 NCRA Financial Assets At Fair Value Through Profit Or Loss
FinancialAssetsAtFairValueThroughProfitOrLoss
200951 usd
CY2022Q4 NCRA Financial Assets At Fair Value Through Profit Or Loss
FinancialAssetsAtFairValueThroughProfitOrLoss
0 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1968719 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3236834 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
22934 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
22703 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1686444 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
844613 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
126358 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
130434 usd
CY2023Q1 us-gaap Goodwill
Goodwill
3905735 usd
CY2022Q4 us-gaap Goodwill
Goodwill
3905735 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4770 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 usd
CY2023Q1 us-gaap Assets
Assets
7714960 usd
CY2022Q4 us-gaap Assets
Assets
8140319 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2482 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2631 usd
CY2023Q1 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
33352 usd
CY2022Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
38388 usd
CY2023Q1 NCRA Advance Receipts
AdvanceReceipts
10700 usd
CY2022Q4 NCRA Advance Receipts
AdvanceReceipts
42880 usd
CY2023Q1 NCRA Due To Related Parties Current1
DueToRelatedPartiesCurrent1
19249 usd
CY2022Q4 NCRA Due To Related Parties Current1
DueToRelatedPartiesCurrent1
18919 usd
CY2023Q1 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
1179768 usd
CY2022Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
1179768 usd
CY2023Q1 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
217105 usd
CY2022Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
214913 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
22312 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
22312 usd
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1932 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1920 usd
CY2023Q1 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
0 usd
CY2022Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
0 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1486900 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1521731 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2023Q1 NCRA Longterm Secured Other Borrowing
LongtermSecuredOtherBorrowing
400459 usd
CY2022Q4 NCRA Longterm Secured Other Borrowing
LongtermSecuredOtherBorrowing
436341 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1887359 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1958072 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9693587 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9693587 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9243587 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9243587 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
9693 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
9243 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
80 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
80 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21108323 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
20484518 usd
CY2023Q1 NCRA Statutory And Other Reserves
StatutoryAndOtherReserves
191219 usd
CY2022Q4 NCRA Statutory And Other Reserves
StatutoryAndOtherReserves
191219 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15735109 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14747461 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
127221 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
103594 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
5701427 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6041193 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
126174 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
141054 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5827601 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6182247 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7714960 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8140319 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3837863 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2919045 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3769207 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2863803 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
68656 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
55242 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1059337 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
860953 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
1059337 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
860953 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-990681 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-805711 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11508 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1002189 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-805711 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1002189 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-805720 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14541 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-987648 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-805720 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1002189 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-805720 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-23288 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-129231 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1025477 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-934951 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-14880 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1010597 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-934951 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1063
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1132
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1063
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1132
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9293587 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7118587 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9293587 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7118587 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1002189 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-805720 usd
CY2023Q1 us-gaap Depreciation
Depreciation
44728 usd
CY2022Q1 us-gaap Depreciation
Depreciation
787 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
231 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-0 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4076 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q1 NCRA Consultancy Services Settled By Equities
ConsultancyServicesSettledByEquities
521100 usd
CY2022Q1 NCRA Consultancy Services Settled By Equities
ConsultancyServicesSettledByEquities
503000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
103155 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
103155 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5098 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-181547 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1343 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
81931 usd
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
0 usd
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
25892 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-82 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-149262 usd
CY2023Q1 NCRA Increase Decrease Operating Lease Rightofuse Asset
IncreaseDecreaseOperatingLeaseRightofuseAsset
-0 usd
CY2022Q1 NCRA Increase Decrease Operating Lease Rightofuse Asset
IncreaseDecreaseOperatingLeaseRightofuseAsset
-0 usd
CY2023Q1 NCRA Increase Decrease In Goodwill
IncreaseDecreaseInGoodwill
-0 usd
CY2022Q1 NCRA Increase Decrease In Goodwill
IncreaseDecreaseInGoodwill
-0 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
4865 usd
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-23414 usd
CY2023Q1 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
0 usd
CY2022Q1 us-gaap Increase Decrease In Notes Payable Current
IncreaseDecreaseInNotesPayableCurrent
-93194 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-149 usd
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-34887 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-4368 usd
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-98670 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
30 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-281200 usd
CY2023Q1 NCRA Increase Decrease In Advance Receipt
IncreaseDecreaseInAdvanceReceipt
32180 usd
CY2022Q1 NCRA Increase Decrease In Advance Receipt
IncreaseDecreaseInAdvanceReceipt
-313423 usd
CY2023Q1 us-gaap Increase Decrease Due From Other Related Parties
IncreaseDecreaseDueFromOtherRelatedParties
-0 usd
CY2022Q1 us-gaap Increase Decrease Due From Other Related Parties
IncreaseDecreaseDueFromOtherRelatedParties
458145 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-364370 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-553267 usd
CY2023Q1 us-gaap Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
857870 usd
CY2022Q1 us-gaap Payments To Acquire Oil And Gas Property And Equipment
PaymentsToAcquireOilAndGasPropertyAndEquipment
-0 usd
CY2023Q1 NCRA Purchase Of Financial Assets
PurchaseOfFinancialAssets
200951 usd
CY2022Q1 NCRA Purchase Of Financial Assets
PurchaseOfFinancialAssets
-0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1058821 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
41137 usd
CY2022Q1 us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
3453 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-41137 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3453 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18758 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74488 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1445570 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-482232 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2906074 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2444009 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1460504 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1961777 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4769964 usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
503000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
129231 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
103155 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-805720 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4699630 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6182247 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
23288 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
103155 usd
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
521100 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-1002189 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5827601 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
27470 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7419 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27470 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zuptXMmKNAb1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_z2ifYNUFB7D2">Concentrations of Credit Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were three customers who represent <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zmoNW2HgN6p8" title="Concentration risk">97</span>% of the Company’s total revenue for the three months ended March 31, 2022. There were four customers who represent <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--FourCustomersMember_zeO4gUfBEsc" title="Concentration risk">95</span>% of the Company’s total revenue for the three months ended March 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of single customers who represent 10% or more of the Company’s total accounts receivable, net:</p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zLyyymuLIy77" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> <span><span id="xdx_8B4_zSO7ILM0W8Sh" style="display: none">Schedule of concentrations of credit risk</span></span></td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">March 31, <br/> 2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td><td> </td><td> </td> <td colspan="2" style="text-align: center">(Audited)</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Percentage of the Company’s accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 66%; text-align: justify">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zpRRTY9lNmUj" title="Concentration percentage">52.05</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zTPxcQmLqk33" title="Concentration percentage">50.83</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zKFLH8VEwEka" title="Concentration percentage">19.09</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zhTLi9zurEr7" title="Concentration percentage">14.73</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z36u5dW7bPs" title="Concentration percentage">13.56</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_ziWD7JNiKqsc" title="Concentration percentage">31.82</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Customer D</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zZSXOOxo57v3" title="Concentration percentage">10.29</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp0_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z9Rsocxh4Zm4" title="Concentration percentage">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--AllCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zdFPkWKTjmyi" title="Concentration percentage">94.99</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--AllCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0dRZVYUd5Vl" title="Concentration percentage">97.38</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023Q1 NCRA Global Intangible Low Taxed Income
GlobalIntangibleLowTaxedIncome
152829 usd
CY2023Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
206784 usd
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
209777 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
206784 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
209777 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
91329 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
91781 usd
CY2023Q1 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
0 usd
CY2022Q4 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
0 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
91329 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
91781 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
0 usd
CY2023Q1 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
7419 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
104265 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
59254 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1686444 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
844613 usd
CY2022Q4 us-gaap Payments To Acquire Land
PaymentsToAcquireLand
20000 usd
CY2022Q4 us-gaap Area Of Land
AreaOfLand
229 acre
CY2023Q1 us-gaap Payments To Acquire Land
PaymentsToAcquireLand
857870 usd
CY2023Q1 us-gaap Depreciation
Depreciation
44728 usd
CY2022Q1 us-gaap Depreciation
Depreciation
787 usd
CY2023Q1 NCRA Financial Assets At Fair Value Through Profit Or Loss Funds
FinancialAssetsAtFairValueThroughProfitOrLossFunds
200951 usd
CY2022Q4 NCRA Financial Assets At Fair Value Through Profit Or Loss Funds
FinancialAssetsAtFairValueThroughProfitOrLossFunds
0 usd
CY2023Q1 NCRA Financial Assets At Fair Value Through Profit Or Loss
FinancialAssetsAtFairValueThroughProfitOrLoss
200951 usd
CY2022Q4 NCRA Financial Assets At Fair Value Through Profit Or Loss
FinancialAssetsAtFairValueThroughProfitOrLoss
0 usd
CY2023Q1 NCRA Financial Assets Measured At Fair Value Through Profit Or Loss Current
FinancialAssetsMeasuredAtFairValueThroughProfitOrLossCurrent
0 usd
CY2022Q4 NCRA Financial Assets Measured At Fair Value Through Profit Or Loss Current
FinancialAssetsMeasuredAtFairValueThroughProfitOrLossCurrent
0 usd
CY2023Q1 NCRA Financial Assets Measured At Fair Value Through Profit Or Loss Non Current
FinancialAssetsMeasuredAtFairValueThroughProfitOrLossNonCurrent
200951 usd
CY2022Q4 NCRA Financial Assets Measured At Fair Value Through Profit Or Loss Non Current
FinancialAssetsMeasuredAtFairValueThroughProfitOrLossNonCurrent
0 usd
CY2023Q1 us-gaap Derivative Assets
DerivativeAssets
200951 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
0 usd
CY2023Q1 NCRA Net Gain Changes In Fair Value Of Financial Assets
NetGainChangesInFairValueOfFinancialAssets
1 usd
CY2023Q1 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
0 usd
CY2023Q1 us-gaap Goodwill
Goodwill
3905735 usd
CY2022Q4 us-gaap Goodwill
Goodwill
3905735 usd
CY2022Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
38388 usd
CY2019Q2 NCRA Value Added Tax Rate1
ValueAddedTaxRate1
0.16 pure
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
135325 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
135325 usd
CY2023Q1 NCRA Finite Lived Intangible Assets Translation Adjustments
FiniteLivedIntangibleAssetsTranslationAdjustments
0 usd
CY2022Q4 NCRA Finite Lived Intangible Assets Translation Adjustments
FiniteLivedIntangibleAssetsTranslationAdjustments
0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8967 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4891 usd
CY2023Q1 NCRA Accumulated Impairment Of Intangible Assets Excluding Goodwill
AccumulatedImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2022Q4 NCRA Accumulated Impairment Of Intangible Assets Excluding Goodwill
AccumulatedImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
126358 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
130434 usd
CY2023Q1 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
217105 usd
CY2022Q4 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
214913 usd
CY2023Q1 us-gaap Other Loans Payable
OtherLoansPayable
617564 usd
CY2022Q4 us-gaap Other Loans Payable
OtherLoansPayable
651254 usd
CY2022Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
2:3 reverse stock split
CY2019Q2 NCRA Value Added Tax Rate2
ValueAddedTaxRate2
0.13 pure
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
9886 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
11788 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
9886 usd
CY2022Q1 us-gaap Lease Cost
LeaseCost
11788 usd
CY2023Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
0 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
0 usd
CY2023Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
870 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
861 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
32482 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37527 usd
CY2023Q1 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
33352 usd
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0.2000 pure
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0.2000 pure
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0154 pure
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.1585 pure
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.1029 pure
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0 pure
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0 pure
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0 pure
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0005 pure
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0120 pure
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
0.0100 pure
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.0811 pure
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.0535 pure
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0100 pure
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23391 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23391 usd
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
0 usd
CY2023Q1 NCRA Deferred Tax Assets Valuation Allowance Currents
DeferredTaxAssetsValuationAllowanceCurrents
0 usd
CY2022Q4 NCRA Deferred Tax Assets Valuation Allowance Currents
DeferredTaxAssetsValuationAllowanceCurrents
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
23391 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
23391 usd
CY2023Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95844 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95844 usd
CY2023Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 usd
CY2023Q1 NCRA Valuation Allowance Deferred Tax Asset Change In Amount1
ValuationAllowanceDeferredTaxAssetChangeInAmount1
0 usd
CY2022 NCRA Valuation Allowance Deferred Tax Asset Change In Amount1
ValuationAllowanceDeferredTaxAssetChangeInAmount1
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95844 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95844 usd
CY2023Q1 NCRA Due To Related Parties Current1
DueToRelatedPartiesCurrent1
19249 usd
CY2022Q4 NCRA Due To Related Parties Current1
DueToRelatedPartiesCurrent1
18919 usd
CY2023Q1 us-gaap Revenues
Revenues
5352 usd
CY2022Q1 us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10707150 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7138587 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7138587 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9693587 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9243587 shares
CY2020Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.50
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.50
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0116 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0116 pure
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y3M21D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y3M21D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4815 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4815 pure
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
103155 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
413453 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11114097 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11114097 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y11M26D
CY2021Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.001
CY2021Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
2.50
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-987648 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-805720 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9293587 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7118587 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9293587 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7118587 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1063
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1132
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.1063
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.1132

Files In Submission

Name View Source Status
ncra-20230331_def.xml Edgar Link unprocessable
ncra-20230331_cal.xml Edgar Link unprocessable
ncra-20230331_pre.xml Edgar Link unprocessable
0001683168-23-003342-index-headers.html Edgar Link pending
0001683168-23-003342-index.html Edgar Link pending
0001683168-23-003342.txt Edgar Link pending
0001683168-23-003342-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ncra-20230331.xsd Edgar Link pending
nocera_ex3101.htm Edgar Link pending
nocera_ex3102.htm Edgar Link pending
nocera_ex3201.htm Edgar Link pending
nocera_ex3202.htm Edgar Link pending
nocera_i10q-033123.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
ncra-20230331_lab.xml Edgar Link unprocessable
nocera_i10q-033123_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending